Discussion stirs around Henry Schein, Inc. (NASDAQ:HSIC) this week; here is what analysts are saying.

Henry Schein, Inc. (NASDAQ:HSIC) Logo
Investors sentiment increased to 1.03 in 2018 Q4. Its up 0.03, from 1 in 2018Q3. It improved, as 36 investors sold Henry Schein, Inc. shares while 164 reduced holdings. 67 funds opened positions while 139 raised stakes. 151.55 million shares or 1.14% less from 153.30 million shares in 2018Q3 were reported.
Ameritas Inv Inc has 0.02% invested in Henry Schein, Inc. (NASDAQ:HSIC) for 5,497 shares. Amica Mutual Ins has 0.21% invested in Henry Schein, Inc. (NASDAQ:HSIC) for 20,652 shares. 19,329 were reported by Bnp Paribas Arbitrage Sa. State Common Retirement Fund owns 1.48M shares or 0.17% of their US portfolio. Barnett has 15,470 shares for 0.69% of their portfolio. Cove Street Limited Co reported 1.37% of its portfolio in Henry Schein, Inc. (NASDAQ:HSIC). Fiera Cap has 183,688 shares for 0.05% of their portfolio. Commonwealth Bank Of Aus has 21,712 shares. Moreover, Victory Mngmt Inc has 0.01% invested in Henry Schein, Inc. (NASDAQ:HSIC) for 46,601 shares. Fifth Third National Bank accumulated 596 shares. Dupont Mgmt accumulated 1,966 shares. State Of Tennessee Treasury Department reported 0.16% in Henry Schein, Inc. (NASDAQ:HSIC). Earnest Prns Ltd Limited Liability Company accumulated 80 shares or 0% of the stock. San Francisco Sentry Inv Gp (Ca) accumulated 49 shares. Legal And General Gru Public Ltd Co has invested 0.06% in Henry Schein, Inc. (NASDAQ:HSIC).

Since November 30, 2018, it had 1 buying transaction, and 3 selling transactions for $8.47 million activity. $738,655 worth of Henry Schein, Inc. (NASDAQ:HSIC) shares were sold by McKinley David. Another trade for 69,000 shares valued at $5.96 million was sold by BERGMAN STANLEY M. On Monday, December 3 PALADINO STEVEN sold $1.90 million worth of Henry Schein, Inc. (NASDAQ:HSIC) or 21,110 shares.

Henry Schein, Inc. (NASDAQ:HSIC) Ratings Coverage

Among 8 analysts covering Henry Schein (NASDAQ:HSIC), 3 have Buy rating, 2 Sell and 3 Hold. Therefore 38% are positive. Henry Schein had 12 analyst reports since January 2, 2019 according to SRatingsIntel. The firm earned “Hold” rating on Thursday, February 21 by Robert W. Baird. UBS maintained Henry Schein, Inc. (NASDAQ:HSIC) rating on Monday, February 25. UBS has “Sell” rating and $57 target. The firm has “Hold” rating by Stifel Nicolaus given on Thursday, February 21. The firm earned “Buy” rating on Tuesday, February 19 by Craig Hallum. The firm has “Hold” rating given on Monday, March 25 by Robert W. Baird. The stock of Henry Schein, Inc. (NASDAQ:HSIC) earned “Buy” rating by Barrington on Thursday, February 21. The firm earned “Equal-Weight” rating on Thursday, February 21 by Barclays Capital. As per Thursday, January 3, the company rating was downgraded by Evercore. On Wednesday, January 2 the stock rating was downgraded by Robert W. Baird to “Neutral”. Below is a list of Henry Schein, Inc. (NASDAQ:HSIC) latest ratings and price target changes.

27/04/2019 Broker: BidaskScore Rating: Hold Upgrade
18/04/2019 Broker: Guggenheim Rating: Buy New Target: $72 Initiates Coverage On
25/03/2019 Broker: Robert W. Baird Rating: Hold New Target: $63 Maintain
25/02/2019 Broker: UBS Rating: Sell New Target: $57 Maintain
21/02/2019 Broker: Stifel Nicolaus Rating: Hold New Target: $65 Maintain
21/02/2019 Broker: Robert W. Baird Rating: Hold New Target: $59 Maintain
21/02/2019 Broker: Barrington Rating: Buy New Target: $72 Maintain
21/02/2019 Broker: Barclays Capital Old Rating: Equal-Weight New Rating: Equal-Weight Old Target: $73 New Target: $63 Maintain
19/02/2019 Broker: Craig Hallum Rating: Buy New Target: $72 Maintain
17/01/2019 Broker: UBS Rating: Sell New Target: $73 Initiates Coverage On

The stock increased 1.86% or $1.24 during the last trading session, reaching $67.95. About 1.62M shares traded. Henry Schein, Inc. (NASDAQ:HSIC) has risen 20.17% since May 8, 2018 and is uptrending. It has outperformed by 15.80% the S&P500.

Henry Schein, Inc. provides health care services and products to dental practitioners and laboratories, animal health clinics, physician practices, government, institutional health care clinics, and other alternate care clinics worldwide. The company has market cap of $10.16 billion. It operates through two divisions, Health Care Distribution, and Technology and Value-Added Services. It has a 19.47 P/E ratio. The Health Care Distribution segment offers dental products, including infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, dental implants, gypsum, acrylics, articulators, abrasives, dental chairs, delivery units and lights, X-ray supplies and equipment, and high-tech and digital restoration equipment, as well as equipment repair services.

More notable recent Henry Schein, Inc. (NASDAQ:HSIC) news were published by: Nasdaq.com which released: “Can Dental Growth Drive Henry Schein’s (HSIC) Q1 Earnings? – Nasdaq” on May 01, 2019, also Nasdaq.com with their article: “Health Care Sector Update for 05/07/2019: PINC,CPRX,HSIC,REGN,SNY – Nasdaq” published on May 07, 2019, Finance.Yahoo.com published: “4 Health Care Stocks That Are Starting to Heat Up – Yahoo Finance” on April 26, 2019. More interesting news about Henry Schein, Inc. (NASDAQ:HSIC) were released by: Nasdaq.com and their article: “Why Henry Schein Stock Dropped 27% Today (But Not Really) – Nasdaq” published on February 08, 2019 as well as Seekingalpha.com‘s news article titled: “Schein to distribute MindChild fetal monitoring system – Seeking Alpha” with publication date: April 25, 2019.

Henry Schein, Inc. (NASDAQ:HSIC) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.